Effect of substrate residues on the P2' preference of retroviral proteinases (Q28372993)

1

0 references

P Bagossi

2

0 references

T D Copeland

3

0 references

S Oroszlan

4

0 references

J M Louis

5

0 references

J Tözsér

Three-dimensional structures of HIV-1 and SIV protease product complexes

6

0 references

language of work or name

English

0 references

publication date

September 1999

0 references

published in

FEBS Journal

0 references

volume

264

0 references

issue

3

0 references

page(s)

921-9

0 references

cites work

1 reference

https://api.crossref.org/works/10.1046/J.1432-1327.1999.00687.X

Structural basis for specificity of retroviral proteases

21 April 2017

1 reference

https://api.crossref.org/works/10.1046/J.1432-1327.1999.00687.X

Closing in on human immunodeficiency virus-1.

21 April 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00687.X

Subsite preferences of retroviral proteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00687.X

Specificity of retroviral proteases: an analysis of viral and nonviral protein substrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00687.X

Comparison of the HIV-1 and HIV-2 proteinases using oligopeptide substrates representing cleavage sites in Gag and Gag-Pol polyproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00687.X

Kinetic and modeling studies of S3-S3' subsites of HIV proteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00687.X

Different requirements for productive interaction between the active site of HIV-1 proteinase and substrates containing -hydrophobic*hydrophobic- or -aromatic*pro- cleavage sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00687.X

On the size of the active site in proteases. I. Papain

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00687.X

Extensive polymorphisms observed in HIV-1 clade B protease gene using high-density oligonucleotide arrays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00687.X

The p2gag peptide, AEAMSQVTNTATIM, processed from HIV-1 Pr55gag was found to be a suicide inhibitor of HIV-1 protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00687.X

Crystal structure of human immunodeficiency virus (HIV) type 2 protease in complex with a reduced amide inhibitor and comparison with HIV-1 protease structures

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00687.X

Crystallographic analysis of human immunodeficiency virus 1 protease with an analog of the conserved CA-p2 substrate -- interactions with frequently occurring glutamic acid residue at P2' position of substrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00687.X

Autoprocessing of the HIV-1 protease using purified wild-type and mutated fusion proteins expressed at high levels in Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00687.X

Selective phosphinate transition-state analogue inhibitors of the protease of human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00687.X

Moloney murine leukemia virus protease: bacterial expression and characterization of the purified enzyme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00687.X

Studies on the substrate specificity of the proteinase of equine infectious anemia virus using oligopeptide substrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00687.X

Human immunodeficiency virus, type 1 protease substrate specificity is limited by interactions between substrate amino acids bound in adjacent enzyme subsites

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00687.X

Substrate-dependent mechanisms in the catalysis of human immunodeficiency virus protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00687.X

X-ray crystallographic structure of a complex between a synthetic protease of human immunodeficiency virus 1 and a substrate-based hydroxyethylamine inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00687.X

Activity of linked HIV-1 proteinase dimers containing mutations in the active site region

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00687.X

Structure of equine infectious anemia virus proteinase complexed with an inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00687.X

CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00687.X

The effect of salt on the Michaelis Menten constant of the HIV-1 protease correlates with the Hofmeister series.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00687.X

The HIV-1 protease as enzyme and substrate: mutagenesis of autolysis sites and generation of a stable mutant with retained kinetic properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00687.X

Predicting human immunodeficiency virus protease cleavage sites in proteins by a discriminant function method

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00687.X

Natural variation in HIV-1 protease, Gag p7 and p6, and protease cleavage sites within gag/pol polyproteins: amino acid substitutions in the absence of protease inhibitors in mothers and children infected by human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00687.X